Article Versions Notes

Kim M-H, Lim H-J, Bak SG, Park E-J, Jang H-J, Lee SW, Lee S, Lee KM, Cheong SH, Lee S-J, et al. Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling. Pharmaceuticals. 2020; 13(12):468. https://doi.org/10.3390/ph13120468

Kim, Mi-Hwa, Hyung-Jin Lim, Seon Gyeong Bak, Eun-Jae Park, Hyun-Jae Jang, Seung Woong Lee, Soyoung Lee, Kang Min Lee, Sun Hee Cheong, Seung-Jae Lee, and et al. 2020. "Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling" Pharmaceuticals 13, no. 12: 468. https://doi.org/10.3390/ph13120468

Kim, M.-H., Lim, H.-J., Bak, S. G., Park, E.-J., Jang, H.-J., Lee, S. W., Lee, S., Lee, K. M., Cheong, S. H., Lee, S.-J., & Rho, M.-C. (2020). Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling. Pharmaceuticals, 13(12), 468. https://doi.org/10.3390/ph13120468